8 Acquired growth hormone resistance in adults
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abribat, 1993, Insulin-like growth factor-I blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn, Clinical Endocrinology, 39, 583, 10.1111/j.1365-2265.1993.tb02413.x
Arnold, 1993, Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure, Clinical Science, 84, 655, 10.1042/cs0840655
Baruch, 1991, Decreased serum growth hormone-binding protein in patients with liver cirrhosis, Journal of Clinical Endocrinology and Metabolism, 73, 777, 10.1210/jcem-73-4-777
Behrman, 1995, The effect of growth hormone on nutritional markers in enterally fed immobilised trauma patients, Journal of Parenteral and Enteral Nutrition, 19, 41, 10.1177/014860719501900141
De Benedetti, 1997, Interleukin-6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunded growth in children with chronic inflammation, Journal of Clinical Investigation, 99, 643, 10.1172/JCI119207
van den Berghe, 1994, Growth hormone secretion in critical illness: effect of dopamine, Journal of Clinical Endocrinology and Metabolism, 79, 1141, 10.1210/jc.79.4.1141
Berneis, 1996, Metabolic actions of growth hormone: direct and indirect, Baillière's Clinical Endocrinology and Metabolism, 10, 337, 10.1016/S0950-351X(96)80470-8
Carlin, 1994, A possible explanation for growth hormone resistance in chronic renal failure, Medical Hypotheses, 43, 193, 10.1016/0306-9877(94)90064-7
Cotterill, 1996, The differential regulation of the circulating levels of the insulin-like growth factor binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery, Clinical Endocrinology, 44, 91, 10.1046/j.1365-2265.1996.649471.x
Cuneo, 1995, Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease, Clinical Endocrinology, 32, 265, 10.1111/j.1365-2265.1995.tb02031.x
Cuthbertson, 1931, Observations on the disturbance of metabolism produced by injury to the limbs, Quarterly Journal of Medicine, 2, 233
Cwyfan-Hughes, 1992, The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery, Journal of Endocrinology, 135, 135, 10.1677/joe.0.1350135
Davenport, 1992, Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery, Journal of Clinical Endocrinology and Metabolism, 75, 590, 10.1210/jc.75.2.590
Davies, 1991, The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness, Journal of Endocrinology, 130, 469, 10.1677/joe.0.1300469
Donahue, 1989, Response of IGF-I to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status, American Journal of Clinical Nutrition, 50, 962, 10.1093/ajcn/50.5.962
Douglas, 1990, Metabolic effects of recombinant human growth hromone: isotopic studies in the postabortive state and during total parenteral nutrition, British Journal of Surgery, 77, 785, 10.1002/bjs.1800770722
Ellis, 1996, Changes in body composition of human immuno-deficiency virus-infected males receiving insulin-like growth factor I and growth hormone, Journal of Clinical Endocrinology and Metabolism, 81, 3033, 10.1210/jc.81.8.3033
Fouque, 1995, Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients, Kidney International, 47, 869, 10.1038/ki.1995.130
Fouque, 1995, Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients, Kidney International, 47, 876, 10.1038/ki.1995.131
Frayn, 1984, Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes, Clinical Endocrinology, 20, 179, 10.1111/j.1365-2265.1984.tb00073.x
Garcia-Mayor, 1993, Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects, Clinical Endocrinology, 39, 337, 10.1111/j.1365-2265.1993.tb02374.x
Giudice, 1995, IGF binding protein-3 protease regulation: how sweet it is!, Journal of Clinical Endocrinology and Metabolism, 80, 2279, 10.1210/jc.80.8.2279
Gottardis, 1991, Improvement of septic syndrome after administration of recombinant human growth hormone?, Journal of Trauma, 31, 81, 10.1097/00005373-199101000-00015
Haffner, 1994, Metabolic clearance of recombinant human growth hormone in health and chronic renal failure, Journal of Clinical Investigation, 93, 1163, 10.1172/JCI117069
Haffner, 1997, Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-liable subunit and growth hormone binding protein in nephrotic children, Kidney International, 52, 802, 10.1038/ki.1997.397
Hartman, 1992, Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men, Journal of Clinical Endocrinology and Metabolism, 74, 757, 10.1210/jc.74.4.757
Hawker, 1987, Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients, Critical Care Medicine, 15, 732, 10.1097/00003246-198708000-00004
Hermansson, 1997, Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery, Journal of Clinical Endocrinology and Metabolism, 82, 421, 10.1210/jc.82.2.421
Hulting, 1984, Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia, Acta Endocrinologica, 106, 305, 10.1530/acta.0.1060305
Hung, 1985, Characteristics of somatotropic growth hormone binding to homologous liver plasma membranes, Molecular and Cellular Endocrinology, 39, 189, 10.1016/0303-7207(85)90062-0
Isley, 1983, Dietary components that regulate serum somatomedin-C concentrations in humans, Journal of Clinical Investigation, 71, 175, 10.1172/JCI110757
Jacob, 1990, IGF-I, a marker of undernutrition in hemodialysis patients, American Journal of Clinical Nutrition, 52, 39, 10.1093/ajcn/52.1.39
Jeevanandam, 1992, Decreased growth hormone levels in the catabolic phase of severe injury, Surgery, 111, 495
Jenkins, 1996, Growth hormone therapy for protein catabolism, Quarterly Journal of Medicine, 89, 813, 10.1093/qjmed/89.11.813
Knox, 1995, Increased survival after major thermal injury: the effect of growth hormone therapy in adults, Journal of Trauma, 39, 526, 10.1097/00005373-199509000-00021
Kupfer, 1993, Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by use of both agents simultaneously, Journal of Clinical Investigation, 91, 391, 10.1172/JCI116212
Lee, 1996, A randomized, placebo-controlled trial of combined insulin-like growth factor 1 and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection, Journal of Clinical Endocrinology and Metabolism, 81, 2968, 10.1210/jc.81.8.2968
Lieberman, 1994, Anabolic effects of recombinant insulin-like growth factor-I in cachetic patients with the acquired immunodeficiency syndrome, Journal of Clinical Endocrinology and Metabolism, 78, 404, 10.1210/jc.78.2.404
Maheshwari, 1992, Growth hormone binding protein in patients with renal failure, Acta Endocrinologica, 127, 485, 10.1530/acta.0.1270485
Mandrup-Poulsen, 1995, Cytokines and the endocrine system. I. The immunoendocrine network, European Journal of Endocrinology, 133, 665, 10.1530/eje.0.1330660
Melarvie, 1995, Pulsatile nature of growth hormone levels in critically ill trauma victims, Surgery, 117, 402, 10.1016/S0039-6060(05)80060-1
Merimee, 1982, Insulin-like growth factors in the fed and fasted states, Journal of Clinical Endocrinology and Metabolism, 55, 999, 10.1210/jcem-55-5-999
Miell, 1992, Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery, Clinical Endocrinology, 37, 542, 10.1111/j.1365-2265.1992.tb01486.x
Minuto, 1989, Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters, Journal of Parenteral and Enteral Nutrition, 13, 392, 10.1177/0148607189013004392
Murphy, 1983, Characterisation of specific growth hormone binding sites in mouse fibroblasts, Endocrinology, 113, 750, 10.1210/endo-113-2-750
Musey, 1993, Differential regulation of IGF-I and IGF-binding protein-1 by dietary composition in humans, American Journal of Medical Science, 305, 131, 10.1097/00000441-199303000-00001
Phillips, 1984, Somatomedin activity in disorders of nutrition and metabolism, Clinical Endocrinology and Metabolism, 13, 145, 10.1016/S0300-595X(84)80012-2
Postel-Vinay, 1995, Nutritional status and growth hormone-binding protein, Hormone Research, 44, 177, 10.1159/000184621
Rabkin, 1996, Pharmacokinetics of insulin-like growth factor-I in advanced chronic renal failure, Kidney International, 49, 1134, 10.1038/ki.1996.164
Rondanelli, 1997, Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection, Aids Research and Human Retroviruses, 13, 1243, 10.1089/aid.1997.13.1243
Ross, 1985, Alteration of pituitary thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis, Annals of Clinical Biochemistry, 22, 156, 10.1177/000456328502200209
Ross, 1991, Levels of GH binding activity, IGFBP-I, insulin, blood glucose and cortisol in intensive care patients, Clinical Endocrinology, 35, 361, 10.1111/j.1365-2265.1991.tb03549.x
Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin like growth factor-I, Clinical Endocrinology, 35, 47, 10.1111/j.1365-2265.1991.tb03495.x
Ross, 1996, Expression of IGF-I and IGF-binding protein genes in cirrhotic liver, Journal of Endocrinology, 149, 209, 10.1677/joe.0.1490209
Sanaka, 1994, IGF-I as an early indicator of malnutrition in patients with end-stage renal disease, Nephron, 67, 73, 10.1159/000187891
Schaefer, 1996, Multifactorial control of the elimination kinetics of unbound (free) growth hormone in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma, Journal of Clinical Endocrinology and Metabolism, 81, 22, 10.1210/jc.81.1.22
Snyder, 1990, Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent, American Journal of Clinical Nutrition, 52, 431, 10.1093/ajcn/52.3.431
Tayek, 1995, Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study, Journal of Clinical Endocrinology and Metabolism, 80, 2082, 10.1210/jc.80.7.2082
Tayek, 1990, Relationship of hepatic glucose production to grwoth hormone and severity of malnutrition in a population with colorectal carcinoma, Cancer Research, 50, 2119
Tönshoff, 1996, Serum of insulin-like growth factors and their binding proteins in children with end-stage renal disease, Pediatric Nephrology, 10, 269, 10.1007/BF00866755
Tönshoff, 1990, Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease, Journal of Pediatrics, 116, 561, 10.1016/S0022-3476(05)81603-8
Tsigos, 1997, Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure, Neuroendocrinology, 66, 54, 10.1159/000127219
Vara-Thorbeck, 1993, Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on post-operative immune function, World Journal of Surgery, 17, 530, 10.1007/BF01655116
Voerman, 1992, Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens, Metabolism, 9, 934, 10.1016/0026-0495(92)90117-S
Wilmore, 1991, Catabolic illness. Strategies for enhancing recovery, New England Journal of Medicine, 325, 695, 10.1056/NEJM199109053251005
Wolf, 1996, Proinflammatory cytokines interleukin 1 beta and tumour necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells, European Journal of Endocrinology, 135, 729, 10.1530/eje.0.1350729
Woods, 1996, Laron syndrome: typical and atypical forms, Baillière's Clinical Endocrinology and Metabolism, 10, 371, 10.1016/S0950-351X(96)80500-3
Woods, 1996, Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor-I gene, New England Journal of Medicine, 335, 1363, 10.1056/NEJM199610313351805
Wright, 1968, Serum growth hormone and glucose intolerance in renal failure, Lancet, ii, 798, 10.1016/S0140-6736(68)92456-2
Yarwood, 1997, Administration of human recombinant insulin like growth factor-1 to critically ill patients, Critical Care Medicine, 25, 1352, 10.1097/00003246-199708000-00023